• News [Showing 20 results of 39 found]

• Death and Dysbiosis: Linking Neonatal Sepsis and Gut Microbes
• How AST Results Support Accurate Antibiotic Therapy in the Battle Against Bacterial Sepsis
• bioMérieux's AST System VITEK® REVEAL Achieves FDA 510(k) Clearance
• Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID 2024
• Q-linea Receives US FDA 510(k) Clearance for the ASTar® System
• Gradientech Signs Exclusive Contract with UK Distributor
• Labor Dr. Brunner Adopts QuantaMatrix dRAST Solution For Routine Clinical Use
• Gradientech’s Diagnostic System QuickMIC® Achieves CE-IVD Approval
• Evaluate the Entire Analytical Process of the BCID2 Panel Assay for Sepsis
• What's on Show at ECCMID 2022 - a rapidmicrobiology Special Focus
• Fast Forward to Actionable Results With Rapid AST
• FDA Clears SeptiCyte® RAPID - The First One-Hour, Direct-from-Blood Sepsis Test
• Rapid Identifier in Suspected Sepsis Cases Takes Just 30 Minutes for Result
• U.S. Patent Covers Gram-Positive and Gram-Negative Sepsis-Causing Bacteria - Looking for Partners
• First Diagnostic Test to Detect 13 AMR-Markers in 5 Hours Granted CE-IVD
• Next Generation Algorithim to Predict the Onset of Sepsis
• Selux Diagnostics 2nd Generation AST Gets Green Light
• CE Certification for DISQVER® - Automated Relevance-Based Detection of Blood Stream Infections
• EU Accelerates Approval of Bloodstream Infection Assay Kit
• T2Bacteria Panel - FDA Cleared Sepsis Test Now Available in More Markets

• Supplier [Showing 12 results of 12 found]

• QuantaMatrix Inc.
• Immunexpress Inc.
• Noscendo GmbH
• Gradientech AB
• Global Sepsis Alliance
• T2 Biosystems
• Specific Technologies
• Primerdesign Ltd
• Momentum Bioscience
• Hycult Biotech
• DiaSorin Molecular LLC
• 3i Diagnostics

• Featured Products:[Showing 1 results of 1 found]

• What's on Show at ECCMID 2022 - a rapidmicrobiology Special Focus